Augustina Isioma Ikusemoro: Is Blood Really Affordable?
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“In many LMICs, families must pay out of pocket for blood transfusions – often at the worst moment of their lives.
Behind every ‘unit’ of blood lies:
- Testing
- Processing
- Cold storage
- Transport
- Skilled expertise
Safe blood saves lives — but it isn’t cheap to produce.
The real tragedy?
- People don’t die because blood doesn’t exist.
- They die because they can’t afford it.
No woman should bleed to death in childbirth.
No child should die of treatable anemia.
No trauma victim should be denied transfusion because of cost.
- Safe blood must be treated as a public health necessity — not a market commodity.
Universal Health Coverage is incomplete without universal access to safe blood.
The Way Forward
Countries that have transformed blood safety share common solutions:
- Strong centralized national blood services
- Government financing and policy commitment
- Universal access models (blood as a public good)
- Investment in infrastructure and workforce
- Robust donor recruitment systems
- Integration into national health insurance schemes
Safe blood systems do not emerge by chance — they are built through leadership, policy, and sustained investment.
- We must stop asking whether blood is expensive.
- We must start asking why patients are the ones paying the price.
Blood is not just a product.
It is a critical component of health system resilience.
And in emergencies, it is the difference between life and death.
If your country still relies heavily on out-of-pocket payments for blood transfusion, what reforms do you believe are most urgent?
Let’s move this conversation from awareness to policy to action.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS